0001104659-22-006736.txt : 20220124 0001104659-22-006736.hdr.sgml : 20220124 20220124105618 ACCESSION NUMBER: 0001104659-22-006736 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220124 DATE AS OF CHANGE: 20220124 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER CORP CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60661 FILM NUMBER: 22547912 BUSINESS ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 978663-3660 MAIL ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP DATE OF NAME CHANGE: 20030721 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER DALTONICS INC DATE OF NAME CHANGE: 20000315 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LAUKIEN JOERG C CENTRAL INDEX KEY: 0001133646 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: C/O BRUKER DALTONICS CITY: BILLERICA STATE: MA ZIP: 01821 SC 13G/A 1 tm224169d1_sc13ga.htm SCHEDULE 13G/A

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

  

SCHEDULE 13G

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 23) *

 

Bruker Corporation

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

116794108

(CUSIP Number) 

 

December 31, 2021

(Date of Event Which Requires Filing of this Statement) 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)

 

x Rule 13d-1(c)

 

¨ Rule 13d-1(d)

  

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

  

 

 

 

   CUSIP NO. 11679410813GPage 2 of 5

 

1

NAME OF REPORTING PERSONS

 

Joerg C. Laukien 

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a) ¨

(b) ¨

 

3

SEC USE ONLY 

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Germany

 

 

 

NUMBER OF 

SHARES 

BENEFICIALLY 

OWNED BY 

EACH 

REPORTING 

PERSON 

WITH 

5

SOLE VOTING POWER

 

7,515,769 shares

 

6

SHARED VOTING POWER 

 

7

SOLE DISPOSITIVE POWER

 

7,515,769 shares 

 

8

SHARED DISPOSITIVE POWER 

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

7,515,769 shares 

 

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) 

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

4.96% 

 

12

TYPE OF REPORTING PERSON (See Instructions)

 

IN 

 

  

 

   CUSIP NO. 11679410813GPage 3 of 5

 

 

Item 1 (a). Name of Issuer: Bruker Corporation

 

Item 1 (b).Address of Issuer’s Principal Executive Offices:

 

40 Manning Road

Billerica, MA 01821

 

Item 2 (a). Name of Person Filing: Joerg C. Laukien

 

Item 2 (b).Address of Principal Business Office or, if none, Residence:

 

Markgrafenstrasse 34
76530 Baden-Baden
Germany

 

Item 2 (c). Citizenship: Germany

 

Item 2 (d). Title of Class of Securities: Common Stock, par value $0.01 per share.

 

Item 2 (e). CUSIP Number: 116794108

 

Item 3.If this Statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: Not applicable.

 

  (a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);

 

  (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);

 

  (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);

 

  (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

 

  (e) ¨ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

  (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

 

  (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

 

  (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

  (i) ¨  A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

(j) ¨A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);

 

  (k) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(K).

 

 

   CUSIP NO. 11679410813GPage 4 of 5

 

Item 4. Ownership

 

  (a) Amount beneficially owned: 7,515,769 shares

 

  (b) Percent of class: 4.96%

 

  (c) Number of shares as to which such person has:

 

  (i) Sole power to vote or to direct the vote 7,515,769 shares
  (ii) Shared power to vote or to direct the vote 0
  (iii) Sole power to dispose or to direct the disposition of 7,515,769 shares
  (iv) Shared power to dispose or to direct the disposition of 0

  

Item 5.Ownership of Five Percent or Less of a Class

 

  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

  

Item 6. Ownership of More than Five Percent on Behalf of Another Person

 

  Not applicable.

 

Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

 

  Not applicable.

 

Item 8.Identification and Classification of Members of the Group

 

  Not applicable.

 

Item 9.Notice of Dissolution of Group

 

  Not applicable.

 

Item 10.Certification

 

  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

 

   CUSIP NO. 11679410813GPage 5 of 5

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

  

Dated: January 24, 2022

  /s/ Joerg C. Laukien
  Joerg C. Laukien